In this study, a significant difference in serum PGRN concentrations was observed between malignant tumors and the control group (3.289 vs. 2.054 ng/mL, p = 0.0012), while no significant difference was found between benign tumors and the control group. The gene discussed is GRN; the disease is benign neoplasm.